SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 59.36 |
Enterprise Value ($M) | 69.05 |
Book Value ($M) | 28.67 |
Book Value / Share | 1.86 |
Price / Book | n/a |
NCAV ($M) | -18.77 |
NCAV / Share | -1.22 |
Price / NCAV | -3.16 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.00 |
Return on Assets (ROA) | n/a |
Return on Equity (ROE) | -0.82 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.85 |
Current Ratio | 0.85 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 35.00 |
Assets | 82.44 |
Liabilities | 53.77 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 12.53 |
Operating Income | -7.56 |
Net Income | -6.25 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 1.78 |
Cash from Investing | 5.85 |
Cash from Financing | 6.09 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
10,028 | 62,456 | 16.06 | |
65,709 | 153,097 | 42.92 | |
37,237 | 146,294 | 25.45 | |
119,783 | 292,384 | 40.97 | |
(click for more detail) |
Similar Companies | |
---|---|
ABEO – Abeona Therapeutics Inc. | ABVC – ABVC BioPharma, Inc. |
ACB – Aurora Cannabis Inc. | ACHV – Achieve Life Sciences, Inc. |
ACXP – Acurx Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io